Production of tumor angiogenesis factor by cell culture
US4229532A · kind A · utility
5Cited by
2References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 29, 1978 |
| Grant date | Oct 21, 1980 |
| Priority date | — |
| Expiry date | Dec 29, 1998 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S435/948
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
Process for the production of human TAF in vitro comprising growing the human osteosarcoma cell line MG-63 in agitated, liquid suspension of nutrient culture medium at about 35.degree.-38.degree. C. for a sufficient time to elaborate TAF and recovering the resulting TAF from the cells or cell product.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.